PLAU and breast carcinoma: In one study, Lee et al. demonstrated that the combination of Au and mesupron, a urokinase-type plasminogen activator inhibitor currently undergoing clinical trials in breast cancer, promoted the inhibition of breast cancer cell proliferation and induced cell cycle arrest and apoptosis, while also significantly increasing reactive oxygen species within cancer cells [97].